TMS Co (TSE:4891) ROCE %: 0.00% (As of Dec. 2025)


TSE:4891 TMS Co Ltd TSE:4891
32 GF Score
Price 円103.00
! 1 Warning Sign
View Full Analysis

What is TMS Co ROCE %?

TMS Co TSE:4891 -0.96% 32 ROCE % is 0.00% as of Dec. 2025. GuruFocus rates TSE:4891 with a GF Score™ of 32/100. The stock has 1 warning sign investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. TMS Co's annualized ROCE % for the quarter that ended in Dec. 2025 was 0.00%.

TMS Co  (TSE:4891) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

TMS Co ROCE % Related Terms

TMS Co ROCE % Historical Data

* Premium members only.

The historical data trend for TMS Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TMS Co ROCE % Chart

TMS Co Annual Data
Trend Feb21 Feb22 Feb23 Feb24 Feb25
ROCE %
-64.00 63.42 -16.86 -26.31 -28.94

TMS Co Quarterly Data
Feb21 Feb22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Feb25 May25 Aug25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -29.54 0.00 -37.11 -26.03 0.00
TSE:4891
32GF Score
TMS Co Ltd TSE:4891
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TMS Co ROCE % Calculation

TMS Co's annualized ROCE % for the fiscal year that ended in Feb. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Feb. 2025 )  (A: Feb. 2024 )(A: Feb. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Feb. 2025 )  (A: Feb. 2024 )(A: Feb. 2025 )
=-907.791/( ( (3554.754 - 97.689) + (3032.269 - 216.781) )/ 2 )
=-907.791/( (3457.065+2815.488)/ 2 )
=-907.791/3136.2765
=-28.94 %

TMS Co's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Aug. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Aug. 2025 )(Q: Dec. 2025 )
=0/( ( (3122.129 - 130.027) + (2865.277 - 94.146) )/ 2 )
=0/( ( 2992.102 + 2771.131 )/ 2 )
=0/2881.6165
=0.00 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 0.00% mean?
TMS Co (TSE:4891) has a ROCE % of 0.00% as of Dec. 2025.
Is TMS Co's ROCE % too high?
TMS Co's current ROCE % is 0.00%. Overall, TMS Co has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does TMS Co's ROCE % compare to VRTX and REGN?
TMS Co's ROCE % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. TMS Co's current ROCE % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TMS Co stock overvalued right now?
TMS Co (TSE:4891) has a current ROCE % of 0.00%. The current ROCE % is 0.00%. TMS Co's overall GF Score™ is 32/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For TMS Co (TSE:4891), the current ROCE % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TMS Co Business Description

Address 1-9-11F, Fuchu-cho, Fuchu-shi, Tokyo, JPN, 183-0055
TMS Co Ltd is focused on researching, developing, manufacturing, and selling pharmaceuticals. The company is involved in conducting research and development of SMTP compounds, which are drug candidate substances targeting soluble epoxide hydrolase (sEH), an enzyme found in the human body. It is developing sEH inhibitors for various inflammatory diseases. The company's clinical pipeline comprises three compounds: TMS-007 (being developed as a potential treatment for acute cerebral infarction), which is in the late clinical stage, TMS-010, and JX09 (for resistant and poorly controlled hypertension) and TMS-008 (to target acute inflammatory diseases such as kidney injury and cancer cachexia), which are in the early clinical stage. In addition, it has TMS-009 as a backup compound for TMS-008.
32GF Score

Get the complete analysis for TSE:4891

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円103.00
Price